Orphan Therapeutics Accelerator Inc.
Fiscal year ending 2024. Filed on November 14, 2025.
54 Morton Street
Andover, Massachusetts 01810
Orphan Therapeutics Accelerator Inc. (EIN: 99-3630868) has filed an IRS Form 990 in fiscal year 2024. In its fiscal year 2024 IRS Form 990 filing, Orphan Therapeutics Accelerator Inc., a 501(c)(3) charitable organization, reported compensation for 6 employees. Among the employees shown here, the average compensation is $100,593. The highest compensated employee at Orphan Therapeutics Accelerator Inc. is Donald Craig Martin with fiscal year 2024 compensation of $153,000.
Revenue, expenses, and employee compensation
Revenue
Expenses
Employee compensation
Reported Compensated Employees
Mission Statement
The specific and primary purpose of the Orphan Therapeutics Accelerator is to engage in charitable and scientific activities within the meaning of Section 501(c)(3) of the Code, including, but not limited to, the following activities: a. Providing, expanding access to, and resolving barriers to the development of therapeutic resources in the form of drugs, therapies, and other related treatments to rare diseases (collectively, the "Therapies"), so as to provide accessible treatments and potential cures to rare diseases that, otherwise, would not be available (such purposes, the "Charitable Purposes"). b. Addressing and resolving scientific barriers to development of the Therapies, which the Accelerator will accomplish via research as it acquires and shepherds the Therapies through late-stage clinical trials, so as to provide accessible treatments and potential cures for rare diseases without known and accessible treatments (such purposes, the "Scientific Purposes").
Revisions to this organization profile
Get an email when new compensation information is released for Orphan Therapeutics Accelerator Inc.
Be the first to know when new IRS Form 990 data is published for this organization.
